For a short-term investment strategy, the company has poor fundamentals.
Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Analysts covering this company mostly recommend stock overweighting or purchase.
With an expected P/E ratio at 45.57 and 35.78 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company is not the most generous with respect to shareholders' compensation.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.